公开(公告)号：US20230040770A1

公开(公告)日：2023-02-09

申请号：US17427490

申请日：2020-01-30

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Yasushi HATTORI ,  Yuhei MIYANOHANA ,  Tatsuki KAJITA ,  Tatsuki KOIKE ,  Yasutaka HOASHI ,  Norihito TOKUNAGA ,  Alexander Martin PAWLICZEK ,  Tsuneo ODA ,  Tohru MIYAZAKI ,  Yoshiteru ITO ,  Kohei TAKEUCHI ,  Keisuke IMAMURA ,  Takahiro SUGIMOTO

IPC: C07D403/06 ,  C07D207/14

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.